Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Hair transplantation improves life quality and self-esteem in men with male pattern baldness.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

People with alopecia areata face challenges but find ways to cope and live fulfilling lives.

Alopecia areata in Romania has a high economic burden, with significant costs and unequal healthcare access.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Atopic dermatitis and alopecia areata have a major global socioeconomic impact, needing more research and better healthcare alignment.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Alopecia areata care in Poland needs better guidelines, access to treatments, and psychological support.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Caregivers of teens with alopecia areata face significant mental and work-related challenges.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Alopecia areata in Brazil causes significant psychosocial impacts, with limited access to advanced treatments, especially in public healthcare.

Alopecia areata severity and symptoms vary by race and ethnicity.

The article discusses various treatments for different types of non-scarring hair loss.

Stress may affect alopecia areata, but it's not a confirmed trigger.

Topical JAK inhibitors may help treat some skin conditions but need more research.